Printed and Published by: Dr Jayashree B Keshav on behalf of Himalaya Wellness Company Printed at: M/s Sri Sudhindra Offset Process, #97, DT Street, 8th Cross, Malleshwaram, Bengaluru 560003 Published from: Himalaya Wellness Company, Makali, Bengaluru 562162 Editor: Dr Jayashree B Keshav In line with our commitment toward a green future, Capsule newsletter is printed with vegetable-based inks on eco-friendly paper made from sustainable sources. Registered with the Registrar of Newspapers for India under R.N. 9073/63 • ISSN 0927-9681 ® Regd. Trade Mark Only for reference by a registered medical practitioner, hospital, or laboratory Protects the liver in NAFLD • Restores the metabolic efficiency of the liver • Modulates lipotropic activity and thus prevents fatty infiltration • Exhibits antiperoxidative activity and improves insulin sensitivity • Exhibits anti-inflammatory action • Arrests the progression of the disease Indication: NAFLD Dosage: 1–2 tablets twice daily. In India, 56.5% of patients with type 2 diabetes have nonalcoholic fatty liver disease. Free fatty acids Oxidative stress Insulin sensitivity Liv.52 DS ( TA B L E T ) Unparalleled in liver care Liv.52 DS — Unparalleled in liver care — J Assoc Physicians India. 2013;61(7):448-453. Printed and Published by: Dr Jayashree B Keshav on behalf of Himalaya Wellness Company Printe at: M/s Sri Sudhindra Offs t Process, #97, DT Street, 8th Cross, Malleshwaram, Bengaluru 560003 Published from: Himalaya Wellness Company, Makali, Bengaluru 562162 Editor: Dr Jayashree B Keshav Registered with the Registrar of Newspapers for India under R.N. 6227/61 www.himalayawellness.com E-mail: write.to.us@himalayawellness.com In line with our commitment toward a green future, Probe magazine is printed with VOC-free, vegetablebased inks on eco-friendly paper made from sustainable sources.
RkJQdWJsaXNoZXIy MjAwNDg=